Research Article| Volume 58, ISSUE 4, P547-551, April 2009

Download started.


Serum levels of angiopoietin-related growth factor in diabetes mellitus and chronic hemodialysis


      Angiopoietin-related growth factor (AGF) was recently introduced as a novel liver-derived protein that antagonizes obesity and insulin resistance. In the current study, we investigated circulating AGF levels in relation to renal function and type 2 diabetes mellitus (T2DM). Angiopoietin-related growth factor was determined by enzyme-linked immunosorbent assay in subjects with a glomerular filtration rate greater than 50 mL/min (n = 60, 30 diabetic and 30 nondiabetic) and in patients on chronic hemodialysis (CD; n = 60, 32 diabetic and 28 nondiabetic). Furthermore, AGF was correlated to clinical and biochemical measures of renal function, glucose and lipid metabolism, as well as inflammation. Median serum AGF levels were significantly lower in CD patients (125.9 ± 96.3 μg/L) as compared with subjects with a glomerular filtration rate greater than 50 mL/min (164.0 ± 95.4 μg/L) (P < .05). Furthermore, AGF serum levels were significantly increased in diabetic patients (161.7 ± 114.2 μg/L) as compared with nondiabetic subjects (123.0 ± 88.2 μg/L) (P < .01). Moreover, CD negatively and T2DM positively predicted AGF concentrations in multiple regression analysis. In addition, fasting serum glucose was independently and positively correlated with circulating AGF in all patients and controls. Our results suggest that renal dysfunction is negatively and T2DM is positively associated with AGF serum levels. Further studies are needed to better elucidate the physiologic significance of circulating AGF in human disease.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Metabolism - Clinical and Experimental
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Fasshauer M.
        • Paschke R.
        Regulation of adipocytokines and insulin resistance.
        Diabetologia. 2003; 46: 1594-1603
        • Trujillo M.E.
        • Scherer P.E.
        Adipose tissue–derived factors: impact on health and disease.
        Endocr Rev. 2006; 27: 762-778
        • Hotamisligil G.S.
        • Shargill N.S.
        • Spiegelman B.M.
        Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance.
        Science. 1993; 259: 87-91
        • Kharitonenkov A.
        • Shiyanova T.L.
        • Koester A.
        • et al.
        FGF-21 as a novel metabolic regulator.
        J Clin Invest. 2005; 115: 1627-1635
        • Oike Y.
        • Akao M.
        • Yasunaga K.
        • et al.
        Angiopoietin-related growth factor antagonizes obesity and insulin resistance.
        Nat Med. 2005; 11: 400-408
        • Zoccali C.
        • Mallamaci F.
        • Tripepi G.
        • et al.
        Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease.
        J Am Soc Nephrol. 2002; 13: 134-141
        • Merabet E.
        • Dagogo-Jack S.
        • Coyne D.W.
        • et al.
        Increased plasma leptin concentration in end-stage renal disease.
        J Clin Endocrinol Metab. 1997; 82: 847-850
        • Seeger J.
        • Ziegelmeier M.
        • Bachmann A.
        • et al.
        Serum levels of the adipokine vaspin in relation to metabolic and renal parameters.
        J Clin Endocrinol Metab. 2008; 93: 247-251
        • Ziegelmeier M.
        • Bachmann A.
        • Seeger J.
        • et al.
        Serum levels of the adipokine RBP-4 in relation to renal function.
        Diabetes Care. 2007; 30: 2588-2592
        • Matthews D.R.
        • Hosker J.P.
        • Rudenski A.S.
        • et al.
        Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man.
        Diabetologia. 1985; 28: 412-419
        • Kratzsch J.
        • Berthold A.
        • Lammert A.
        • et al.
        A rapid, quantitative immunofunctional assay for measuring human leptin.
        Horm Res. 2002; 57: 127-132
        • Su Z.
        • Korstanje R.
        • Tsaih S.W.
        • Paigen B.
        Candidate genes for obesity revealed from a C57BL/6J x 129S1/SvImJ intercross.
        Int J Obes (Lond). 2008; 32: 1180-1189
        • Kitazawa M.
        • Ohizumi Y.
        • Oike Y.
        • Hishinuma T.
        • Hashimoto S.
        Angiopoietin-related growth factor suppresses gluconeogenesis through the Akt/forkhead box class O1-dependent pathway in hepatocytes.
        J Pharmacol Exp Ther. 2007; 323: 787-793
        • Zhang Y.
        • Scarpace P.J.
        The role of leptin in leptin resistance and obesity.
        Physiol Behav. 2006; 88: 249-256